These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 9592984

  • 1. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
    Llamas P, Cabrera R, Gómez-Arnau J, Fernández MN.
    Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
    [Abstract] [Full Text] [Related]

  • 2. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
    Segal HC, Hunt BJ, Cottam S, Downing A, Beard C, Francis JL, Potter D, Tan KC.
    Transplantation; 1994 Dec 27; 58(12):1356-60. PubMed ID: 7528949
    [Abstract] [Full Text] [Related]

  • 3. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
    Kuyvenhoven JP, Molenaar IQ, Verspaget HW, Veldman MG, Palareti G, Legnani C, Moolenburgh SE, Terpstra OT, Lamers CB, van Hoek B, Porte RJ.
    Thromb Haemost; 2004 Mar 27; 91(3):506-13. PubMed ID: 14983226
    [Abstract] [Full Text] [Related]

  • 4. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
    Molenaar IQ, Legnani C, Groenland TH, Palareti G, Begliomini B, Terpstra OT, Porte RJ.
    Liver Transpl; 2001 Oct 27; 7(10):896-903. PubMed ID: 11679989
    [Abstract] [Full Text] [Related]

  • 5. Changes in the contact system during orthotopic liver transplantation with and without aprotinin.
    Segal HC, Hunt BJ, Cottam S, Beard C, Francis JL, Potter D, Tan KC.
    Transplantation; 1995 Feb 15; 59(3):366-70. PubMed ID: 7532878
    [Abstract] [Full Text] [Related]

  • 6. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A, Mateo J, Oliver A, Litvan H, Murillo J, Souto JC, Fontcuberta J.
    Haematologica; 2000 Dec 15; 85(12):1277-84. PubMed ID: 11114135
    [Abstract] [Full Text] [Related]

  • 7. Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT).
    Himmelreich G, Dooijewaard G, Breinl P, Bechstein WO, Neuhaus P, Kluft C, Riess H.
    Thromb Haemost; 1993 Jan 11; 69(1):56-9. PubMed ID: 8446939
    [Abstract] [Full Text] [Related]

  • 8. [Reduction of the need for blood derivatives in liver transplantation using aprotinin].
    Monedero P, Páramo JA, Carrascosa F, Herrero JI, Hidalgo F, Iribarren MJ, García-Pedrajas F.
    Rev Esp Anestesiol Reanim; 1995 Mar 11; 42(3):82-6. PubMed ID: 7539932
    [Abstract] [Full Text] [Related]

  • 9. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R, Golański J, Chizyński K, Iwaszkiewicz A, Zasłonka J, Pietrucha T, Chrul S, Watała C.
    Med Sci Monit; 2000 Mar 11; 6(4):722-8. PubMed ID: 11208399
    [Abstract] [Full Text] [Related]

  • 10. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
    Dalmau A, Sabaté A, Koo M, Bartolomé C, Rafecas A, Figueras J, Jaurrieta E.
    Liver Transpl; 2004 Feb 11; 10(2):279-84. PubMed ID: 14762867
    [Abstract] [Full Text] [Related]

  • 11. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Findlay JY, Rettke SR, Ereth MH, Plevak DJ, Krom RA, Kufner RP.
    Liver Transpl; 2001 Sep 11; 7(9):802-7. PubMed ID: 11552215
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE, van der Linden PJ, Melot C, Wijns W, de Pauw L, Vandestadt J, Hut F, Pradier O.
    Transfusion; 2006 Apr 11; 46(4):595-605. PubMed ID: 16584436
    [Abstract] [Full Text] [Related]

  • 13. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.
    Anesth Analg; 2008 Nov 11; 107(5):1469-78. PubMed ID: 18931201
    [Abstract] [Full Text] [Related]

  • 14. Transfusion requirements are correlated with the degree of proteolysis of von Willebrand factor during orthotopic liver transplantation.
    Lattuada A, Mannucci PM, Chen C, Legnani C, Palareti G.
    Thromb Haemost; 1997 Aug 11; 78(2):813-9. PubMed ID: 9268177
    [Abstract] [Full Text] [Related]

  • 15. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
    Wang Y, Liu Y, Han R, Zhu Z, Zhang Y, Wang X, Wang L, Shen Z.
    Thromb Res; 2008 Aug 11; 122(2):161-6. PubMed ID: 18048090
    [Abstract] [Full Text] [Related]

  • 16. Decreasing blood product requirements after orthotopic liver transplantation.
    Gordon PC, James MF, Spearman CW, Millar AJ, Kahn D.
    S Afr J Surg; 2002 May 11; 40(2):46-8. PubMed ID: 12162230
    [Abstract] [Full Text] [Related]

  • 17. Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation.
    Patrassi GM, Viero M, Sartori MT, De Silvestro G, Rossaro L, Burra P, Nolli ML, Piccinni P, Bassi N.
    Transfusion; 1994 Jun 11; 34(6):507-11. PubMed ID: 7517586
    [Abstract] [Full Text] [Related]

  • 18. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H, Du Buit C, Soria J, Touchot B, Chollet B, Commin PL, Conseiller C, Echter E, Soria C.
    Thromb Haemost; 1994 Sep 11; 72(3):438-43. PubMed ID: 7531877
    [Abstract] [Full Text] [Related]

  • 19. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB, Lemke J, Lange M, Rastan A, Mohr FW.
    Ann Thorac Surg; 2008 May 11; 85(5):1662-8. PubMed ID: 18442562
    [Abstract] [Full Text] [Related]

  • 20. Influence of prostaglandin E1 infusion on hemostasis in orthotopic liver transplantation.
    Himmelreich G, Hundt K, Bechstein WO, Rossaint R, Neuhaus P, Riess H.
    Semin Thromb Hemost; 1993 May 11; 19(3):273-8. PubMed ID: 7689752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.